← Back
Data updated: Mar 10, 2026
MALLINCKRODT IRELAND
RespiratoryCardiovascularGastroenterology
MALLINCKRODT IRELAND is a specialty pharmaceutical company focused on Respiratory, Cardiovascular, Gastroenterology. Key products include TERLIVAZ.
1952
Since
4
Drugs
-
Trials
0
Approved (2yr)
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Respiratory 33%
1 drugs Phase 1: 1
Cardiovascular 29%
1 drugs
Gastroenterology 29%
0 drugs Phase 3: 1 Phase 2: 1
Immunology 10%
0 drugs Phase 1: 2
Pipeline Strength Pro
Loading...
Competitors Pro
Novartis big-pharma
Cardiovascular, Immunology, Respiratory
LEGACY PHARMA big-pharma
Respiratory, Gastroenterology, Immunology, Cardiovascular
BAUSCH specialty
Immunology, Cardiovascular, Gastroenterology
AstraZeneca big-pharma
Respiratory, Cardiovascular, Immunology
COREPHARMA other
Cardiovascular, Respiratory, Immunology, Gastroenterology
Active (3)
Discontinued (1)
Company Info
- First Approval
- 1952-04-29
- Latest
- 2024-02-29
- Applications
- 3